Lantern Pharma (LTRN) Stock: Buy, Sell, or Hold?
LTRN - Lantern Pharma Inc. Common Stock
$0.68
0.00 (0.07%)
▲
5d:
+2.72%
30d:
-50.72%
90d:
-75.09%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 11, 2026
19d
Get Alerted When LTRN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: LTRN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: LTRN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: LTRN is currently trading at $0.68, which is considered oversold relative to its 30-day fair value range of $0.73 to $1.51.
Technical Outlook: Technically, LTRN is in a strong downtrend. Immediate support is located at $0.60, while resistance sits at $0.90.
Market Sentiment: LTRN scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $17.50 (+2456.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LTRN is in a strong downtrend. Immediate support is located at $0.60, while resistance sits at $0.90.
Market Sentiment: LTRN scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $17.50 (+2456.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.73 -
$1.51
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2456.6% below Wall St target ($17.50)
- WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.73 -
$1.51
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.60
Resistance Level
$0.90
Current Trend
Strong Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.34
Wall Street Target
$17.50
(+2456.6%)
Share & Embed Analysis
Last updated: October 22, 2026 10:01 AM ET
Data refreshes hourly during market hours. Next update: 11:01 AM
Data refreshes hourly during market hours. Next update: 11:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LTRN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$92 | 72 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
23 analysts |
$108 | 70 BUY |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$130 | 76 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$283 | 51 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 69 BUY |
